Maze Therapeutics, Inc. (MAZE)

Maze Therapeutics Statistics

Total Valuation

Market Cap	n/a
Enterprise Value	n/a

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	1.03
Interest Coverage	5.89

Financial Efficiency

Return on equity (ROE) is -19.41% and return on invested capital (ROIC) is -31.29%.

Return on Equity (ROE)	-19.41%
Return on Assets (ROA)	n/a
Return on Capital (ROIC)	-31.29%
Revenue Per Employee	$1.38M
Profits Per Employee	-$150,959
Employee Count	121
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, MAZE has paid $1.45 million in taxes.

Income Tax	1.45M
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	n/a
200-Day Moving Average	n/a
Relative Strength Index (RSI)	n/a
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, MAZE had revenue of $167.50 million and -$18.27 million in losses.

Revenue	167.50M
Gross Profit	167.50M
Operating Income	64.26M
Pretax Income	-16.82M
Net Income	-18.27M
EBITDA	-16.69M
EBIT	-20.26M
Earnings Per Share (EPS)	n/a

Balance Sheet

The company has $149.61 million in cash and $79.16 million in debt, giving a net cash position of $70.45 million.

Cash & Cash Equivalents	149.61M
Total Debt	79.16M
Net Cash	70.45M
Net Cash Per Share	n/a
Equity (Book Value)	-284.53M
Book Value Per Share	n/a
Working Capital	136.40M

Cash Flow

In the last 12 months, operating cash flow was $77.76 million and capital expenditures -$576,000, giving a free cash flow of $77.19 million.

Operating Cash Flow	77.76M
Capital Expenditures	-576,000
Free Cash Flow	77.19M
FCF Per Share	n/a

Margins

Gross margin is 100.00%, with operating and profit margins of 38.36% and -10.91%.

Gross Margin	100.00%
Operating Margin	38.36%
Pretax Margin	-10.04%
Profit Margin	-10.91%
EBITDA Margin	-9.97%
EBIT Margin	-12.10%
FCF Margin	46.08%

Dividends & Yields

MAZE does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	n/a
FCF Yield	n/a

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a